More like ~4% for middle-aged adults (https://t.co/cotu8XCoD0 @KrishnaAragam) but agree these percentages translate to large numbers for CVD. And could be even larger for younger adults.
RT @pnatarajanmd: Our prior work led by @KrishnaAragam describing the clinical scope of this scenario https://t.co/cotu8XTZuy @JACCJournals…
RT @pnatarajanmd: Our prior work led by @KrishnaAragam describing the clinical scope of this scenario https://t.co/cotu8XTZuy @JACCJournals…
Our prior work led by @KrishnaAragam describing the clinical scope of this scenario https://t.co/cotu8XTZuy @JACCJournals @DoGenetics @SDamrauer https://t.co/tf57PHFnLF
We applied a genome-wide PRS of 6+ million variants from https://t.co/UKHRQ9vkbS @KrishnaAragam @pnatarajanmd to ~6K individuals from @BronfmanInst @IcahnMountSinai. We identified individuals with very high or low PRS who were NOT at high clinical risk of
@NouraAbulHusn's familial hypercholesterolemia paper in @ScienceMagazine 2016 (https://t.co/EEzDg1OX6z) was my inspiration for our CAD PRS paper in @JACCJournals 2020 (https://t.co/cc8enUHqiW)
Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease. https://t.co/eHwicReqPd
@cecilejanssens Looking forward to it! Does it fit into your narrative? https://t.co/sH7zS4YStC
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease | JACC: Journal of the American College of Cardiology https://t.co/52rCvuEy9v
RT @JACCJournals: Polygenic #cvCAD risk is not well-captured by current guidelines. Can we do better? @Pnatarajanmd et al. discuss in #JACC…
RT @JACCJournals: Polygenic #cvCAD risk is not well-captured by current guidelines. Can we do better? @Pnatarajanmd et al. discuss in #JACC…
RT @JACCJournals: Polygenic #cvCAD risk is not well-captured by current guidelines. Can we do better? @Pnatarajanmd et al. discuss in #JACC…
RT @JACCJournals: Polygenic #cvCAD risk is not well-captured by current guidelines. Can we do better? @Pnatarajanmd et al. discuss in #JACC…
RT @JACCJournals: Polygenic #cvCAD risk is not well-captured by current guidelines. Can we do better? @Pnatarajanmd et al. discuss in #JACC…
Polygenic #cvCAD risk is not well-captured by current guidelines. Can we do better? @Pnatarajanmd et al. discuss in #JACC: https://t.co/SwbOzQqknD https://t.co/rPZ3oTB6Sm
Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease. https://t.co/uaP7fPjnfP
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
#Cardionews 💌 Should we integrate genetic risk into coronary artery disease assessment algorithms to improve their yield? New research examines how much we might miss. #cardiotwitter #cardiosmart #research #JACC #Genetics #MedTwitter #medicine https://t.c
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @patrick_ellinor: Terrific work Krishna and Pradeep!
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @GiordanoBotta: These are the evidences of the clinical value of CAD PRS we were waiting for. #CAD #Polygenicriskscore
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
Great work @pnatarajanmd @KrishnaAragam Would love to chat about other preventative strategies that could be use for high patients based on PRS.
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
These are the evidences of the clinical value of CAD PRS we were waiting for. #CAD #Polygenicriskscore
Congratulations krishna, Pradeep and the team!! Great work!! Thank you for the education !!
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
This is so cool, great work
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
Terrific work Krishna and Pradeep!
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
RT @pnatarajanmd: A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic test…
A patient shows up to the office with a CAD polygenic risk score in-hand from direct-to-consumer or research genetic testing. What to do? Our work led by @KrishnaAragam highlights an opportunity in 3 ethnically-diverse health systems. https://t.co/Sw6MACiv
Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease | JACC: Journal of the American College of Cardiology https://t.co/s8dGLkRis5